key: cord-0905917-xj16dip8 authors: Amin, Saiful; Aktar, Salma; Rahman, Md. Mijanur; Hassan Chowdhury, Mohammed Mehadi title: NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity date: 2021-11-25 journal: Microbes Infect DOI: 10.1016/j.micinf.2021.104913 sha: 52b09e66f39a1e91c4ccbc8644ea74e90e99cf96 doc_id: 905917 cord_uid: xj16dip8 NLRP3 inflammasome is a critical immune component that plays a crucial role in mounting innate immune responses. The deleterious effects of inflammasome activation have been correlated with the COVID-19 disease severity. In the presence of several underlying disorders, the immune components of our bodies are dysregulated, creating conditions that could adversely affect us other than providing a required level of protection. In this review, we focused on the occurrence of NLRP3 inflammasome activation in response to SARS-COV-2 infection, dysregulation of NLRP3 activation events in the presence of several comorbidities, the contribution of activated NLRP3 inflammasome to the severity of COVID-19, and available therapeutics for the treatment of such NLRP3 inflammasome related diseases based on current knowledge. The primed state of immunity in individuals with comorbidities (risk factors) could accelerate many deaths and severe COVID-19 cases via activation of NLRP3 inflammasome and the release of downstream inflammatory molecules. Therefore, a detailed understanding of the host-pathogen interaction is needed to clarify the pathophysiology and select a potential therapeutic approach. The outcome of the NLRP3 inflammasome activation is a natural host cell response to SARS- , including IL-6, IL-12, IL-27, TNF, IFN-162 , and IL-1 [25] . The production of pro-IL-1 is a priming step, which should be cleaved by 163 caspase-1 into active IL-1 . The second signal comes from cytosolic K + efflux, which formed 164 from viral or environmental damage molecules induced oxidative stress. 165 Several reports have been published on how SARS-COV-2 triggers NLRP3 inflammasome The major molecules regulated by NLRP3 inflammasome that are constantly detected in 215 COVID-19 cases can be listed as potential biomarkers of nlrp3 activation, so that the diagnosis 216 and clinical treatment will be more effective and rapid. A recent review conducted by Setu M. In this scenario, we listed some possible risk factors and their mechanisms that may contribute 240 to NLRP3-dependent inflammation associated with COVID-19 in Table 1 . The intracellular 580 sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of 581 caspase-1 Critical Role for Cryopyrin/Nalp3 in Activation of Caspase-1 in Response to Viral Infection and Double-stranded RNA*>. 584 Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in 587 the Obesity and COVID-19 Severity in a Designated 589 Hospital in Shenzhen Pathological inflammation in patients with COVID-19: a key role for monocytes 591 and macrophages SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA 593 sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway Inflammasomes are 596 activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and 601 therapeutic strategies Monocytes Drive Influenza A Virus-Mediated Lung Injury in Juvenile Mice HIV-associated 616 neurocognitive disorder--pathogenesis and prospects for treatment IL-1β Production through 618 the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver 619 Inflammation and Disease Cyclic GMP-AMP is an endogenous second 621 messenger in innate immune signaling by cytosolic DNA CoV-2: a storm is raging Cellular immune responses 625 to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB CD4+ T cells are important in control of SARS-CoV infection Clinical features of patients infected with 2019 628 novel coronavirus in Wuhan, China Impaired NLRP3 630 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during 631 coronavirus infection SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes SARS-CoV-2 triggers inflammatory responses Severe acute respiratory syndrome coronavirus E protein transports calcium 650 ions and activates the NLRP3 inflammasome Complement associated 652 microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five 653 cases Viroporins: structure and biological functions Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids Structural basis of coronavirus E protein interactions with 660 human PALS1 PDZ domain Viral proteins function as ion channels Severe Acute Respiratory Syndrome Coronavirus 664 Viroporin 3a Activates the NLRP3 Inflammasome Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Inflammasome to Induce Podocyte Injury and Mitochondrial Dysfunction C3a modulates IL-1β 675 secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome 676 activation SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a 678 trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells Complement lysis: a hole is a hole The complement membrane attack 683 complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation The dynamic changes in 688 cytokine responses in COVID-19: a snapshot of the current state of knowledge Longitudinal analyses reveal 691 immunological misfiring in severe COVID-19 Lactate dehydrogenase, an independent risk 693 factor of severe COVID-19 patients: a retrospective and observational study SARS-CoV-2 infects blood 696 monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release Acute 699 lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor 700 induction How Age Influences the Host Immune Response to Coronavirus Infections? Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation Mitochondrial DNA Mutations and Apoptosis in Mitochondrial DNA that 710 escapes from autophagy causes inflammation and heart failure Telomere dysfunction induces 712 metabolic and mitochondrial compromise The SARS-CoV-2 receptor, ACE-2, 714 is expressed on many different cell types: implications for ACE-inhibitor-and angiotensin II receptor 715 blocker-based antihypertensive therapies-reply COVID-19 Infection and Circulating ACE2 Levels: Protective 717 Role in Women and Children Aging in COVID-19: Vulnerability, 719 immunity and intervention Case-Fatality Rate and Characteristics of Patients Dying in Cytokine and NLRP3 Inflammasome Activation and Increased Vascular Permeability in Diabetes: A Possible Fatal Link With Worst COVID-19 Infection Outcomes? Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 728 1 and Type 2 Diabetes Thioredoxin-interacting protein links oxidative 730 stress to inflammasome activation Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal 733 Pneumonia in SARS-CoV-Infected Mice survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain Obesity Phenotypes, Diabetes, and Cardiovascular Diseases The Stormy Link Between Obesity and COVID-741 19 Properties and functions of adipose tissue macrophages in obesity Risk of COVID-19 for patients with obesity Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of 750 observational studies with meta-analysis Obesity predisposes to the risk of higher 752 mortality in young COVID-19 patients Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation Clinical characteristics and outcomes of 757 [72] WHO Statement: Tobacco Use and COVID-19 Statement: Tobacco Use and COVID-19. Available online The Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain-Containing 3 Inflammasome Regulates Bronchial Epithelial Cell Injury and Proapoptosis after Exposure to Biomass Fuel Smoke A large lung gene expression study identifying IL1B 768 as a novel player in airway inflammation in COPD airway epithelial cells Cigarette smoke inhibits the 771 NLRP3 inflammasome and leads to caspase-1 activation via the TLR4-TRIF-caspase-8 axis in human 772 macrophages COVID-19 and Smoking: What Evidence Needs Our 774 Attention? COVID-19 and smoking: A systematic review of the evidence Adding Fuel to the Flame Prevalence of Underlying Diseases in Hospitalized 780 Patients with COVID-19: a Systematic Review and Meta-Analysis Risk factors of critical & mortal COVID-19 783 cases: A systematic literature review and meta-analysis Effect of tobacco smoking on the risk 785 of developing community acquired pneumonia: A systematic review and meta-analysis Analysis of factors associated with disease 788 outcomes in hospitalized patients with 2019 novel coronavirus disease Clinical characteristics of 145 patients 791 with corona virus disease 2019 (COVID-19 Epidemiological and clinical characteristics Nicotine and the renin-angiotensin system Sex Differences in Mortality From Sex differences in 800 susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse 801 US metropolitan area Sex differences in immune 803 responses that underlie COVID-19 disease outcomes Single-cell RNA expression profiling of ACE2, the 805 putative receptor of Wuhan 2019-nCov Clinical course and outcomes of critically ill patients 807 with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective Will children reveal 810 their secret? The coronavirus dilemma Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in 815 the Treatment of COVID-19 Anti-inflammatory 817 compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome COVID-19: A Case for Microtubule-driven spatial 831 arrangement of mitochondria promotes activation of the NLRP3 inflammasome The Antimalarial Chloroquine Suppresses LPS Induced NLRP3 Inflammasome Activation and Confers Protection against Murine Endotoxic Shock Hydroxychloroquine Combination Therapy on IgA Nephropathy via Suppressing NF-κB Signaling and 838 NLRP3 Inflammasome Activation by Exosomes in Rats Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation Pro-843 inflammatory Ca++-activated K+ channels are inhibited by hydroxychloroquine Chloroquine to fight COVID-19: A consideration of 846 mechanisms and adverse effects? Coronaviruses and the cardiovascular system: 848 acute and long-term implications Inflammasome as Therapeutic Targets in Cardiovascular Disease Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19? Naunyn